Cells for Cells (C4C), a pioneer in regenerative medicine biotech based in Chile, secured US$ 5.2 million from its historical investors to open a US-based holding company and a spin-off….
Read More
Cells for Cells and Universidad de los Andes were awarded the Fourth National Basal Funding Competition for Scientific and Technological Centers of Excellence, granted by the National Agency for Research…
Cells for Cells (C4C), a pioneering regenerative medicine company based in Santiago, Chile, received news of the obtention of a new CORFO grant that will support the advancement of its...
Read More
Recent Posts
- ISCT highlights observations from major Chilean advanced therapy developer group on Latin American regulation for Regenerative Medicine products in its recent Telegraft issue
- Chile’s Ministry of Science recognizes Cells for Cells as university spin-off success case in white paper
- Cells for Cells treats the first-ever patient with an exosome-produced therapy for osteoarthritis
- Cells for Cells presented groundbreaking results of three extracellular vesicles products at ISCT and ISEV annual meetings
- Cells for Cells featured in Startups Latam’s 2022 report
